Literature DB >> 26732365

Cobaltoceniumethynyl gold(I) as an unusual heterodinuclear bioorganometallic fragment to study the biological properties of alkynyl gold complexes.

S Vanicek1, H Kopacka1, K Wurst1, S Vergeiner2, S Kankowski3, J Schur3, B Bildstein1, I Ott3.   

Abstract

A cobaltoceniumethynyl gold(i) complex with a triphenylphosphane ligand triggered efficient cytotoxic effects in cancer cells in contrast to a derivative with two cobaltocenium moieties. The complex effectively inhibited the enzyme thioredoxin reductase (TrxR) suggesting this enzyme as a possible biological target. The cellular uptake of both metal fragments of the active complex was studied by atomic absorption spectroscopy and indicated a high biological stability of the complex.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26732365     DOI: 10.1039/c5dt04796j

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  3 in total

1.  Direct Amination of Cobaltocenium Hexafluoridophosphate via Vicarious Nucleophilic Substitution.

Authors:  Markus Jochriem; Dominik Bosch; Holger Kopacka; Benno Bildstein
Journal:  Organometallics       Date:  2019-05-17       Impact factor: 3.876

Review 2.  Gold as a Possible Alternative to Platinum-Based Chemotherapy for Colon Cancer Treatment.

Authors:  Inés Mármol; Javier Quero; María Jesús Rodríguez-Yoldi; Elena Cerrada
Journal:  Cancers (Basel)       Date:  2019-06-05       Impact factor: 6.639

3.  Highly Electrophilic, Catalytically Active and Redox-Responsive Cobaltoceniumyl and Ferrocenyl Triazolylidene Coinage Metal Complexes.

Authors:  Stefan Vanicek; Maren Podewitz; Jessica Stubbe; Dennis Schulze; Holger Kopacka; Klaus Wurst; Thomas Müller; Petra Lippmann; Simone Haslinger; Herwig Schottenberger; Klaus R Liedl; Ingo Ott; Biprajit Sarkar; Benno Bildstein
Journal:  Chemistry       Date:  2018-01-17       Impact factor: 5.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.